Distribution · MENA · Announced 22 Oct 2026
QOL Medical → Qurqas Pharmaceutical Warehouse
Distribution deal between QOL Medical (United States) and Qurqas Pharmaceutical Warehouse (Saudi Arabia), covering ETHAMOLIN®, announced 22 Oct 2026. Value: Undisclosed.
Parties: QOL Medical (United States) → Qurqas Pharmaceutical Warehouse (Saudi Arabia)
- Deal type
- Distribution
- Value
- Undisclosed
- Territory
- Saudi Arabia
- Therapeutic area
- Other
- Asset
- ETHAMOLIN® (ethanolamine oleate injection 5%) — exclusive Saudi distribution rights until 2030
- Announced
- 22 Oct 2026
Our analysis
On 22 October 2026, Scientific and Medical Equipment House Co. (Tadawul: 4014) announced that its wholly owned subsidiary, Qurqas Pharmaceutical Warehouse Co., has secured exclusive rights to distribute ETHAMOLIN® in Saudi Arabia under an agreement with US-based QOL Medical LLC.
The full analysis is free to read with a work email on this page.
Source: Argaam / Tadawul statement